Suchergebnisse - "Mulinari, Shai"

PubPharm (109)

1

Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis

enthalten in: bioRxiv.org | 2024

von Larkin, J. | Matthes, B. | Azribi, M. | +6

2

Delays in dealing with complaints against drug companies are growing, BMJ finds

enthalten in: BMJ (Clinical research ed.) | 2024

von Boytchev, H. | Mulinari, S. | Ozieranski, P.

3

Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed

enthalten in: bioRxiv.org | 2024

von Nilsonne, G. | Wieschowski, S. | DeVito, N. | +38

4

Race in clinical trials in Sweden : How regulatory and medical standards in clinical research trump the post-racial discourse

enthalten in: Sociology of health & illness | 2024

von Mulinari, S. | Bredström, A.

5

Authors' reply to Fell

enthalten in: BMJ (Clinical research ed.) | 2023

von Mulinari, S. | Ozieranski, P.

CommentOn: BMJ. 2023 Nov 1;383:2477. - PMID 37914191

6

Unethical pharmaceutical marketing : a common problem requiring collective responsibility

enthalten in: BMJ (Clinical research ed.) | 2023

von Mulinari, S. | Ozieranski, P.

CommentIn: BMJ. 2023 Nov 1;383:2477. - PMID 37914191

7

Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: an observational study

enthalten in: bioRxiv.org | 2023

von Larkin, J. | Mulinari, S. | Ozieranski, P. | +4

8

Conceptual unclarity about COVID-19 ethnic disparities in Sweden : Implications for public health policy

enthalten in: Health (London, England : 1997) | 2023

von Bredström, A. | Mulinari, S.

9

International comparison of pharmaceutical industry payment disclosures in the UK and Japan : implications for self-regulation, public regulation, and transparency

enthalten in: Globalization and health | 2023

von Ozieranski, P. | Saito, H. | Rickard, E. | +2

10

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency

enthalten in: Globalization and health | 2023

von Ozieranski, P. | Saito, H. | Rickard, E. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]